Gws Pharma Private Limited - Company Profile

It is a trading private limited company based in Delhi, Delhi, India, established in 2003.
2003 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Gws Pharma Private Limited

Gws Pharma Private Limited, a struck off private limited company, was established on 17 May 2003 in Delhi, Delhi, India. Engaging in retailers within the trading sector, it holds CIN: U24239DL2003PTC120221. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.80 M and a paid-up capital of ₹0.76 M.

Its leadership includes Adhiraj Dutt (Director), Faisal Bin Sami (Director). Past directors included Subhash Chandra Dina, Sheikh Mohammad Razi. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at H-5/16, Ground Floor, Malviay Nagar, Delhi, Delhi, 110017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2003PTC120221

  • Registration Number

    120221

  • Incorporation Date

    17 May 2003

  • Authorized Capital

    ₹0.80 M

  • Paid-Up Capital

    ₹0.76 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.80 M
  • Paid Up Capital ₹ 0.76 M
  • Company Age 23 Year, 1 Month
  • Last Filing with ROC 31 Mar 2015
Company report

Gws Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Gws Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gws Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Adhiraj Dutt Director 01 Jan 2008 Current
Faisal Bin Sami Director 01 Jun 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Jun 2011 Past
Pramod Abcsdd Director 08 May 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gws Pharma.

Enhance accessibility to Gws Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gws Pharma revenue growth over time
Gws Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gws Pharma?

Unlock access to Gws Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gws Pharma?

Unlock and access historical data on people associated with Gws Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gws Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gws Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gws Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Gws Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Gws Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Adhiraj Dutt was appointed as a Director was appointed as a Director on 01 Jan 2008 & has been associated with this company since 18 years 5 months . was documented.

  • Director Appointment

    The activity Faisal Bin Sami was appointed as a Director was appointed as a Director on 01 Jun 2006 & has been associated with this company since 20 years 18 days . was completed.

  • Company Incorporation

    Gws Pharma Private Limited was registered on 17 May 2003 with Roc Delhi & aged 23 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gws Pharma Private Limited?

The CIN of Gws Pharma Private Limited is U24239DL2003PTC120221.

Where is Gws Pharma Private Limited headquartered?

Gws Pharma Private Limited is headquartered at H-5/16, Ground Floor, Malviay Nagar, Delhi, Delhi, 110017.

When was Gws Pharma Private Limited incorporated?

Gws Pharma Private Limited was incorporated on 17 May 2003.

Who are the current directors of Gws Pharma Private Limited?

The current directors of Gws Pharma Private Limited are

What is the primary industry of Gws Pharma Private Limited?

The primary industry of Gws Pharma Private Limited is Trading.

Is Gws Pharma Private Limited a listed company?

Gws Pharma Private Limited is unlisted.

What is the capital structure of Gws Pharma Private Limited?

The authorized capital of Gws Pharma Private Limited is ₹0.80 M, and the paid-up capital is ₹0.76 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available